InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: akhsv777 post# 45883

Thursday, 11/29/2018 9:04:16 AM

Thursday, November 29, 2018 9:04:16 AM

Post# of 48316
These results are why Dr. Robert Pierce who spear-headed the Keytruda program at Merck, went to work for Oncosec to help move combo checkpoint therapy to the next level. Of all the small companies to go to he chose Oncosec. PISCES is the culmination of that decision. FDA approval or two coming next year for Oncosec in melanoma and TNBC.